Warm lung transport device aims to cut transplant failure

NCT ID NCT07340710

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a device that keeps donor lungs warm and breathing during transport, instead of putting them on ice. The goal is to reduce severe lung swelling (edema) after transplant, which can lead to failure. About 450 lung transplant patients will take part, with two-thirds getting the device and one-third getting standard cold storage.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

OCS Lung System (a device that keeps donor lungs warm and breathing during transport)

What this could lead to

If successful, this device could reduce early lung failure after transplant, helping more patients recover without severe complications.

What could go wrong

This trial hasn't started yet, and the device is compared to standard cold storage. It may not show a clear benefit, and device-related risks are possible.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG TRANSPLANT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••